ChemInform Abstract: Current Lead Natural Products for the Chemotherapy of Human Immunodeficiency Virus (HIV) Infection

De Clercq Erik

doi:10.1002/chin.200045286

Back

ChemInform Abstract: Current Lead Natural Products for the Chemotherapy of Human Immunodeficiency Virus (HIV) Infection

Article 2000 en

Abstract

1 min read

Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article1995

ChemInform Abstract: TSAO Derivatives: Highly Specific Inhibitors of Human Immunodeficiency Virus Type‐1 (HIV‐1) Replication

Marı́a-José Camarasa, María‐Jesús Pérez‐Pérez, Sonsoles Velázquez, Ana San‐Félix, Rosa Álvarez, Simon T. Ingate, M. Luísa Jimeno, Anna Karlsson, De Clercq Erik, Jan Balzarini

Article1999

ChemInform Abstract: Inhibition of Human Immunodeficiency Virus Type (HIV‐1) Replication by Some Diversely Functionalized Spirocyclopropyl Derivatives.

Myriam Witvrouw, Christophe Pannecouque, De Clercq Erik, E. FERNANDEZ‐ALVAREZ, José L. Marco

Article2001

ChemInform Abstract: New Developments in Anti‐HIV Chemotherapy

De Clercq Erik

Article1996

ChemInform Abstract: Betulinic Acid Derivatives: A New Class of Specific Inhibitors of Human Immunodeficiency Virus Type 1 Entry.

Françoise Soler, Christèle Poujade, M. Evers, J.‐C. CARRY, Yvette Hénin, Anne Bousseau, Thierry Huet, Rudi Pauwels, De Clercq Erik, J F Mayaux, Jean Bernard Le Pecq, Norbert Dereu

Article1997

ChemInform Abstract: Benzothiadiazine Dioxide Acyclonucleosides as Lead Compounds for the Development of New Agents Against Human Cytomegalovirus and Varicella‐ Zoster Virus Infections.

Ana Martı́nez, Ana Esteban, De Clercq Erik